Compazine: Clinical Trials

12 trials of Compazine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 terminated, 1 unknown. 5 Phase 4, 3 Phase 2, 3 Phase 3, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 45Completed 4, Terminated 1
Phase 23Completed 2, Terminated 1
Phase 33Terminated 2, Completed 1
Not applicable1Unknown 1
Phase 11Completed 1

Follow Compazine: new trials by email Literature Review of Compazine trials Research Report on Compazine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prochlorperazine Maleate Versus Placebo for the Prophylaxis of Acute Mountain Sickness
Prochlorperazine Maleate, Placebo - Acute Mountain Sickness
Phase 2CompletedUniversity of Colorado, Denver572024-08-052024-09-19
Intranasal Ketorolac Trial
Ketorolac, Prochlorperazine, Diphenhydramine - Headache, Migraine
Phase 2TerminatedWashington University School of Medicine412024-01-012026-01-16
Intravenous Fluids in Pediatric Migraine
1/2 maintenance fluids, Ketorolac, Diphenhydramine - Migraine, Migraine in Children
Not applicableUnknownDayton Children's Hospital1342023-06-272023-12-26
Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients
Ondansetron, Dexamethasone, Neurokinin-1 Receptor Antagonist (NK1-RA) - Gynecologic Cancer
Phase 3TerminatedUniversity of Michigan Rogel Cancer Center622020-12-282025-06-18
Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy
Aprepitant 80 mg Oral Capsule, scopolamine transdermal, Total intravenous anesthesia - Post-operative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy
Phase 4CompletedStony Brook University832017-08-282024-02-14
Intravenous Fluids in Benign Headaches Trial
Normal Saline 5mL, Normal Saline 20mL/kg, Prochlorperazine 0.15 mg/kg up to 10 mg IV - Headache
Phase 4CompletedUniversity Medical Center of Southern Nevada582017-05-162024-06-06
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
E7 TCR cells, Aldesleukin, Fludarabine - Papillomavirus Infections, Cervical Intraepithelial Neoplasia
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)2242017-01-272026-03-09
The CHECK Trial: A Comparison of Headache Treatment in the Emergency Department: Compazine Versus Ketamine
Compazine, Ketamine - Headache
Phase 3TerminatedMike O'Callaghan Military Hospital52016-08-012024-03-04
The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine
Prochlorperazine, Ketamine, Diphenhydramine - Headache
Phase 4CompletedUniversity Medical Center of Southern Nevada542016-03-172017-12-11
Hydromorphone Versus Prochlorperazine + Diphenhydramine for Acute Migraine
Hydromorphone, Prochlorperazine, Diphenhydramine - Migraine
Phase 4CompletedMontefiore Medical Center1272015-03-012018-08-31
Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine
Aspirin, Acetaminophen, Caffeine pills, Prochlorperazine 10mg - Migraine Headaches
Phase 4TerminatedAlbert Einstein Healthcare Network932010-11-012020-03-18
Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial
aprepitant, dexamethasone, granisetron hydrochloride - Nausea
Phase 3CompletedJoseph Roscoe10212006-12-012015-11-10

Conditions studied

Headache (5)  ·  Migraine Disorders (5)  ·  Vomiting (2)  ·  Altitude Sickness (1)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Carcinoma in Situ (1)  ·  Inflammatory Breast Neoplasms (1)  ·  Nausea (1)  ·  Papillomavirus Infections (1)  ·  Uterine Cervical Dysplasia (1)  ·  Vulvar Diseases (1)  ·  Vulvar Neoplasms (1)

Sponsors

University Medical Center of Southern Nevada (2)  ·  Albert Einstein Healthcare Network (1)  ·  Dayton Children's Hospital (1)  ·  Joseph Roscoe (1)  ·  Mike O'Callaghan Military Hospital (1)  ·  Montefiore Medical Center (1)  ·  National Cancer Institute (NCI) (1)  ·  Stony Brook University (1)  ·  University of Colorado, Denver (1)  ·  University of Michigan Rogel Cancer Center (1)  ·  Washington University School of Medicine (1)

Countries

United States (12)

Top investigators

Aimee Rolston (1)  ·  Benjamin W Friedman, MD, MS (1)  ·  Christopher Pitotti, MD (1)  ·  Elan Small, MD (1)  ·  Jonathan Elliott, MD (1)  ·  Joseph A Zitek, MD (1)  ·  Joseph A. Roscoe, PhD (1)  ·  Kenneth Deitch, DO (1)  ·  Konstantinos Spaniolas, MD (1)  ·  Scott M Norberg, D.O. (1)  ·  Sophia Rifkin, MD (1)  ·  Tony Zitek, MD (1)

Results publications

PMID 11535479, PMID 12598264, PMID 12764341, PMID 14633551, PMID 15107371, PMID 17157685, PMID 18006188, PMID 18387702, PMID 18534808, PMID 18958996, PMID 20045576, PMID 21880111, PMID 22915657, PMID 23567060, PMID 23936605, PMID 24127709, PMID 24180163, PMID 25366551, PMID 25817884, PMID 29033296, PMID 29046364, PMID 29089172, PMID 2915441, PMID 32620543, PMID 33528788, PMID 33558725, PMID 34363617, PMID 39574186, PMID 7486359, PMID 9707750

NIH funding

U10CA037420 (1)